crs journal reading early stage rectal cancer
DESCRIPTION
CrsTRANSCRIPT
![Page 1: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/1.jpg)
CRS Journal Reading
Reporter R1 : Chiang Kuan Yu
![Page 2: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/2.jpg)
Rectal cancer guideline
![Page 3: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/3.jpg)
Rectal cancer guideline
![Page 4: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/4.jpg)
Abdomino-Perineal resection
![Page 5: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/5.jpg)
Low anterior resection
![Page 6: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/6.jpg)
Total Mesorectal Excision
![Page 7: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/7.jpg)
However
Low recurrence rate with stage I rectal cancer in the range of 4~16% within 5 years.
Local excision remains controversial for T2 tumors
![Page 8: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/8.jpg)
The primary aim To determine:
![Page 9: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/9.jpg)
MATERIALS AND METHODS Retrospective study
Patients with: (175 patients) T1/2 N0 rectal adenocarcinoma LAR, APR, or Transanal local excision Without neoadjuvant or adjuvant CRT Apparent metastases on preoperative CT or PET were excluded.
Between 2000 -2008
At the Brigham and Women’s Hospital or Massachusetts General Hospital
![Page 10: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/10.jpg)
Result
Local Recurrence
Overall Survival
![Page 11: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/11.jpg)
Local Recurrence Time to local recurrence (TTLR)
as a surrogate for absolute risk of local recurrence (LR)
23 (16.8%) patients had a local recurrence. The median time was 1.1 years (0.1–7.8).
![Page 12: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/12.jpg)
Local Recurrence Associated with an increase risk of LR
male sex (HR 2.9, p = 0.02) current alcohol use (HR 2.4, p = 0.04) lymphovascular invasion (HR 2.6, p = 0.05) tumor ulceration (HR 2.9, p = 0.01)
clinical data, race, smoking status, family history, and clinical presentation were not associated with local recurrence.
Tumor size, CRM, histological grade, preoperative CEA, peri-neural invasion, and large-vessel invasion were not related to local failure, although no patient had a positive CRM.
![Page 13: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/13.jpg)
Overall Survival Among these patients, the median overall survival was 12
years.
Associated with decreased survival Age (at diagnosis) > 65 y/o (HR 2.3, p = 0.015), T2 pathologic stage (HR 2.9, p = 0.002), Tumor size >4.5 cm (HR 2.5, p = 0.04).
Within the clinical data, race, smoking status, family history, and clinical presentation were not associated with overall survival.
Degree of circumferential involvement, preoperative CEA, PNI, and large-vessel invasion were unrelated to mortality.
![Page 14: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/14.jpg)
Approach relationship
No significant difference in risk of LR & OS between patients undergoing radical resection or local excision for T1 or T2 tumors.
Interestingly, there was a trend toward a significantly greater risk of LR for patients with pT2 tumors treated with LAR alone
![Page 15: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/15.jpg)
Discussion Male lateral margin
More difficult to obtain in the male pelvis Significantly smaller CRM in men than in women
Male vs female patients A similar proportion of local excisions, LAR, and APR as well
as extent of lymph node dissection. Male patients had a significantly higher proportion of alcohol
users
![Page 16: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/16.jpg)
Discussion Increase in risk of local recurrence in patients with
ulcerated tumors, both after radical surgery and local excision.
Not an independent risk factor for recurrence or mortality, but rather was associated with histological characteristics.
![Page 17: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/17.jpg)
Discussion Alcohol use is a significant prognostic factor for patients
with rectal cancer after resection
Stronger with rectal tumors in comparison with colon tumors (previous study)
Ethanol metabolism genes-encoding dehydrogenases Genotoxic effect
![Page 18: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/18.jpg)
Discussion T2 pathologic stage was an independent prognostic factor
for reduced survival in our patients.
We cannot exclude the possibility of micrometastasis within perirectal or pelvic lymph nodes that were not sampled.
May require radical surgery (ie, APR or LAR) and/or adjuvant therapies to maximize the likelihood of local control and survival
![Page 19: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/19.jpg)
CONCLUSIONS Identification of prognostic factors Promoting individualized treatment
![Page 20: Crs journal reading Early stage Rectal cancer](https://reader034.vdocument.in/reader034/viewer/2022042816/559408af1a28ab79288b474b/html5/thumbnails/20.jpg)